
JNJ
Johnson & Johnson
$174.21
-$1.98(-1.12%)
88
Overall
95
Value
81
Tech
--
Quality
Market Cap
$424.33B
Volume
7.19M
52W Range
$140.68 - $181.16
Target Price
$178.77
Order:
Income Statement
Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
Total Revenue | $70.1B | $71.9B | $76.5B | $81.6B | $82.1B | $82.6B | $93.8B | $80.0B | $85.2B | $88.8B | ||
Total Revenue | $70.1B | $71.9B | $76.5B | $81.6B | $82.1B | $82.6B | $93.8B | $80.0B | $85.2B | $88.8B | ||
COST OF GOODS SOLD | ||||||||||||
Cost of Revenue | $21.5B | $21.7B | $25.4B | $27.1B | $27.6B | $28.4B | $23.4B | $24.6B | $26.6B | $27.5B | ||
GROSS PROFIT | ||||||||||||
Gross Profit | $48.5B | $50.2B | $51.0B | $54.5B | $54.5B | $54.2B | $55.3B | $55.4B | $58.6B | $61.4B | ||
OPERATING EXPENSES | ||||||||||||
Operating Expenses | $30.5B | $29.1B | $32.5B | $34.4B | $34.4B | $34.4B | $40.3B | $33.2B | $36.6B | $40.1B | ||
Research & Development | $9.3B | $9.1B | $11.0B | $11.9B | $12.2B | $12.3B | $15.6B | $14.1B | $15.1B | $17.2B | ||
Research Expense | $9.3B | $9.1B | $11.0B | $11.9B | $12.2B | $12.3B | $15.6B | $14.1B | $15.1B | $17.2B | ||
Selling, General & Administrative | $21.2B | $19.9B | $21.5B | $22.5B | $22.2B | $22.1B | $24.7B | $20.2B | $21.5B | $22.9B | ||
Selling & Marketing Expenses | $2.5B | $2.4B | $2.5B | $2.6B | $2.2B | $2.1B | $2.7B | $700.0M | $500.0M | $600.0M | ||
General & Administrative Expenses | $21.2B | $19.9B | $21.5B | $22.5B | $22.2B | $22.1B | $24.7B | $20.2B | $21.5B | $22.9B | ||
Promotion & Advertising | $2.5B | $2.4B | $2.5B | $2.6B | $2.2B | $2.1B | $2.7B | -- | -- | -- | ||
Salaries & Wages | $-253.0M | $-256.0M | $-275.0M | $-192.0M | $-227.0M | $-210.0M | $-218.0M | -- | -- | -- | ||
Depreciation & Amortization | $3.7B | $3.8B | $5.6B | $6.9B | $7.0B | $7.2B | $7.4B | $7.0B | $7.5B | $7.3B | ||
Depreciation & Amortization | $3.7B | $3.8B | $5.6B | $6.9B | $7.0B | $7.2B | $7.4B | -- | -- | -- | ||
Amortization | $-193.0M | $-75.0M | $-177.0M | $-1.3B | $47.6B | $53.4B | $-9.0M | -- | -- | $-56.0M | ||
Other Operating Expenses | $-570.0M | $-348.0M | $-332.0M | $-242.0M | $-249.0M | $-265.0M | $-242.0M | -- | -- | -- | ||
OPERATING INCOME | ||||||||||||
Operating income | $18.1B | $21.1B | $18.5B | $20.0B | $20.1B | $19.7B | $23.6B | $21.0B | $22.0B | $21.2B | ||
EBITDA | $23.5B | $24.3B | $24.2B | $25.9B | $24.7B | $23.9B | $29.8B | $26.6B | $45.1B | $24.8B | ||
NON-OPERATING ITEMS | ||||||||||||
Interest Expense (Non-Operating) | $552.0M | $726.0M | $934.0M | $1.0B | $318.0M | $201.0M | $183.0M | $276.0M | $772.0M | $755.0M | ||
Intinc | $128.0M | $368.0M | $385.0M | $611.0M | $357.0M | $111.0M | $53.0M | $490.0M | $1.3B | $1.3B | ||
Net Non-Operating Interest Income/Expense | $-424.0M | $-358.0M | $-549.0M | $-394.0M | $39.0M | $-90.0M | $-130.0M | $214.0M | $489.0M | $577.0M | ||
Other Income/Expense | $-2.1B | $484.0M | $-42.0M | $1.4B | $2.5B | $2.9B | $489.0M | $-3.1B | $6.6B | $4.7B | ||
Other Special Charges | $2.1B | $-484.0M | $42.0M | $-1.4B | $-2.5B | $-2.9B | $-489.0M | $-810.0M | $-6.6B | $-4.7B | ||
SPECIAL ITEMS | ||||||||||||
Restructring And Mn A Income | $509.0M | $491.0M | $309.0M | $251.0M | $266.0M | $247.0M | $252.0M | $275.0M | $489.0M | $234.0M | ||
Special Income Charges | $-509.0M | $-491.0M | $-309.0M | $-251.0M | $-266.0M | $-247.0M | $-252.0M | $-275.0M | $-489.0M | $-234.0M | ||
Impairment of Capital Assets | $624.0M | $283.0M | $795.0M | $1.3B | $1.1B | -- | $989.0M | -- | -- | -- | ||
PRE-TAX INCOME | ||||||||||||
EBIT | $19.7B | $20.5B | $18.6B | $19.0B | $17.6B | $16.7B | $22.4B | $19.6B | $37.7B | $17.4B | ||
Pre-Tax Income | $19.2B | $19.8B | $17.7B | $18.0B | $17.3B | $16.5B | $22.8B | $19.4B | $15.1B | $16.7B | ||
INCOME TAX | ||||||||||||
Tax Provision | $3.8B | $3.3B | $16.4B | $2.7B | $2.2B | $1.8B | $1.4B | $3.0B | $1.7B | $2.6B | ||
NET INCOME | ||||||||||||
Net Income | $15.4B | $16.5B | $1.3B | $15.3B | $15.1B | $14.7B | $20.9B | $17.9B | $35.2B | $14.1B | ||
Net Income (Continuing Operations) | $15.4B | $16.5B | $1.3B | $15.3B | $15.1B | $14.7B | $20.9B | $16.4B | $35.2B | $14.1B | ||
Net Income (Discontinued Operations) | $15.4B | $16.5B | $1.3B | $15.3B | $15.1B | $14.7B | $20.9B | $17.9B | $35.2B | $14.1B | ||
Net Income (Common Stockholders) | $15.4B | $16.5B | $1.3B | $15.3B | $15.1B | $14.7B | $20.9B | $17.9B | $35.2B | $14.1B | ||
Normalized Income | -- | -- | -- | $14.4B | -- | -- | -- | -- | -- | -- | ||
TOTALS | ||||||||||||
Total Expenses | $52.0B | $50.8B | $58.0B | $61.5B | $62.0B | $62.9B | $63.7B | $57.8B | $63.1B | $67.6B | ||
SHARE & EPS DATA | ||||||||||||
Average Shares Outstanding | $2.8B | $2.7B | $2.7B | $2.7B | $2.6B | $2.6B | $2.6B | $2.6B | $2.5B | $2.4B | ||
Average Shares Outstanding (Diluted) | $2.8B | $2.8B | $2.7B | $2.7B | $2.7B | $2.7B | $2.7B | $2.7B | $2.6B | $2.4B | ||
Shares Outstanding | $2.8B | $2.7B | $2.7B | $2.7B | $2.6B | $2.6B | $2.6B | $2.6B | $2.4B | $2.4B | ||
Basic EPS | $5.56 | $6.04 | $0.48 | $5.7 | $5.72 | $5.59 | $7.93 | $6.83 | $13.88 | $5.84 | ||
Basic EPS (Continuing Operations) | $5.56 | $6.04 | $0.48 | $5.7 | $5.72 | $5.59 | $7.93 | $6.83 | $5.26 | $5.84 | ||
Diluted EPS | $5.48 | $5.93 | $0.47 | $5.61 | $5.63 | $5.51 | $7.81 | $6.73 | $13.72 | $5.79 | ||
Diluted EPS (Continuing Operations) | $5.48 | $5.93 | $0.47 | $5.61 | $5.63 | $5.51 | $7.81 | $6.73 | $5.2 | $5.79 | ||
Dividend Per Share | $2.95 | $3.15 | $3.32 | $3.54 | $3.75 | $3.98 | $4.19 | $4.45 | $4.7 | -- | ||
OTHER METRICS | ||||||||||||
Basic Discontinuous Operations | -- | -- | -- | -- | -- | -- | -- | -- | $8.62 | -- | ||
Diluted Discontinuous Operations | -- | -- | -- | -- | -- | -- | -- | -- | $8.52 | -- | ||
Gain On Sale Of P P E | $2.6B | $600.0M | $1.3B | $1.2B | $2.2B | -- | -- | -- | -- | -- | ||
Non Recurring Operation Expense | $141.0M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
Other Gand A | $21.2B | $19.9B | $21.5B | $22.5B | $22.2B | $22.1B | $24.7B | $20.2B | $21.5B | $22.9B | ||
Rent And Landing Fees | $316.0M | $330.0M | $372.0M | $332.0M | -- | -- | -- | -- | -- | -- | ||
Restruct | $509.0M | $491.0M | $309.0M | $251.0M | $266.0M | $247.0M | $252.0M | $275.0M | $489.0M | $234.0M |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | JNJ | $174.21 | -1.1% | 7.19M |
3 | ||||
4 | ||||
5 | ||||
6 |